Clinical Trials Logo

Clinical Trial Summary

Prospective pilot study to assess the feasibility and efficacy of intrahepatic plastic biliary stents with a retrieval string in patients with presumed resectable perihilar cholangiocarcinoma requiring biliary drainage of the future liver remnant.


Clinical Trial Description

Background: Pre-operative biliary drainage is advised to treat obstructive jaundice and optimize the clinical condition of patients with presumed resectable perihilar cholangiocarcinoma who are expected to be eligible for major liver resection. However, stent related complications such as cholangitis (37%) and stent dysfunction (19%) occur frequently. Creating the need for numerous re-interventions, re-admissions, delay of diagnostic work-up and potential surgery. Biliary drainage could be optimized by the use of a navel design short fully covered self-expanding metal stent (FCSEMS) which is currently examined in the CHORDA-pilot study. However, FCSEMS placement is not feasible in an considerable number of cases, in these patients the use of a plastic stent with a retrieval string could be beneficial over standard plastic stent placement, which makes removal possible although the stent does not reach into the duodenum. Objective: To explore feasibility and efficacy of endoscopic drainage of patients with presumed perihilar cholangiocarcinoma eligible for major liver resection using a plastic stent with a retrieval string. Study population: Patients with presumed perihilar cholangiocarcinoma that are judged eligible for major liver resection and require endoscopic biliary drainage of the future liver remnant. lntervention: Endoscopic drainage of the future liver remnant using a plastic biliary stent with retrieval string (diameter 7 or 1 0Fr). Primary outcome: Number of severe drainage related complications between inclusion and exploratory laparotomy. In patients who will not undergo exploratory laparotomy, the number of drainage-related complications will be measured until 7 days after the decision to cancel exploratory laparotomy or 90 days after inclusion, whichever comes first. Secondary study parameters/outcome of the study (if applicable): Secondary outcomes: technical and therapeutic success of biliary drainage, individual components of primary endpoints and quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05874934
Study type Interventional
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Jeska A. Fritzsche, MD
Phone +20 444 0613
Email j.a.fritzsche@amsterdamumc.nl
Status Recruiting
Phase N/A
Start date March 1, 2023
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04993131 - Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma N/A
Recruiting NCT05546372 - Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma N/A
Recruiting NCT05024513 - Biliary Drainage Plus HAIC in Locally Advanced pCCA Phase 2
Completed NCT05402618 - Minimally Invasive Versus Open Surgery for PHC
Recruiting NCT04561453 - Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Active, not recruiting NCT05078801 - Endoscopic Versus Radiologic Biliary Drainage for Perihilar Malignant Obstruction
Recruiting NCT05430698 - PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma Phase 2
Recruiting NCT06125769 - LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) N/A
Active, not recruiting NCT05563870 - Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma N/A
Recruiting NCT04846192 - Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma
Completed NCT06357117 - Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma